metricas

Enfermería Intensiva

Sugerencias
Enfermería Intensiva Prevalence, characteristics, and associated factors of dyskalemia in Moroccan in...
Información de la revista
Vol. 37. Núm. 1.
(Enero - Marzo 2026)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
449
Vol. 37. Núm. 1.
(Enero - Marzo 2026)
Original article

Prevalence, characteristics, and associated factors of dyskalemia in Moroccan intensive care units over a 28-month period: A cross-sectional correlational study

Prevalencia, características y factores asociados de la discalemia en las unidades de cuidados intensivos en Marruecos durante un periodo de 28 meses: un estudio transversal
Visitas
449
Kamal Takhdata,
Autor para correspondencia
kamal.takhdat@ced.uca.ma

Corresponding author.
, Salma El Hamdoua,b, Houda El Bannaouia,b, Ahmed Rhassane El Adibc
a Higher Institute of Nursing Professions and Health Techniques, Marrakesh, Morocco
b Emergency Department, Mohammed VI University Hospital Center, Marrakech, Morocco
c Mohammed VI Faculty of Medecine-UM6SS, Casablanca, Morocco
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract
Introduction

Dyskalemia disturbs electrophysiological homeostasis and even cause several life-threatening conditions. Improved understanding of dyskalemia risk factors is clinically relevant for prompt and effective dyskalemia treatment. This study aims to analyze dyskalemia prevalence and risk factors in two adult medical and surgical intensive care units (ICUs) in a Moroccan university hospital.

Methods

A retrospective cross-sectional study was conducted from January 1st 2022 to April 30, 2024. A total of 1274 patients’ medical records were examined, yielding for 549 dyskalemic patients. Single-factor and multi-factor logistic regression analyses were conducted to investigate associations between dyskalemia and the risk factors related to patients’ characteristics, comorbidities, and therapeutic agents.

Results

The prevalence of dyskalemia was found at 43%, with a dyskalemic patients’ mean age of 48.3 (±18.6). Over 62% of them developed dyskalemia during ICU stay. Multivariable analyses showed that the risk of hypokalemia was associated to female gender, diabetic ketoacidosis, anticancer drugs, heparin (LMWH), and insulin. However, the risk of hyperkalemia was associated with male gender, chronic kidney failure, metabolic acidosis, burns, blood transfusion, and propofol as a sedative agent.

Conclusion

Several associated factors of the risk of dyskalemia were identified. Critical care nurses should pay particular attention to high-risk patients of dyskalemia and be proactive in identifying early signs of dyskalemia in order to achieve targeted risk assessment, improve early diagnosis, and management of the patients’ conditions.

Keywords:
Dyskalemia
Associated factors
Intensive care
Resumen
Introducción

La discalemia altera la homeostasis electrofisiológica e incluso es causa de varias afecciones potencialmente mortales. Una mejor comprensión de los factores de riesgo de la discalemia es clínicamente relevante para un tratamiento rápido y eficaz. Este estudio tiene como objetivo analizar la prevalencia y los factores de riesgo de la discalemia en 2 unidades de cuidados intensivos (UCI) médicos y quirúrgicos de adultos de un hospital universitario marroquí.

Método

Se realizó un estudio transversal retrospectivo desde el 1 de enero de 2022 hasta el 30 de abril de 2024. Se examinaron las historias clínicas de 1.274 pacientes, con un total de 549 pacientes discalémicos. Se realizaron análisis de regresión logística de factor único y multifactorial para investigar las asociaciones entre la discalemia y los factores de riesgo relacionados con las características de los pacientes, las comorbilidades y los agentes terapéuticos.

Resultados

La prevalencia de discalemia fue del 43%, con una edad media de los pacientes discalémicos de 48,3 (±18,6). Más del 62% de ellos desarrollaron discalemia durante su estancia en la UCI. Los análisis multivariables mostraron que el riesgo de hipopotasemia estaba asociado al sexo femenino, la cetoacidosis diabética, los fármacos contra el cáncer, la heparina y la insulina. El riesgo de hiperpotasemia se asoció al sexo masculino, la insuficiencia renal crónica, la acidosis metabólica, las quemaduras, la transfusión de sangre y el propofol.

Conclusión

Se identificaron varios factores asociados al riesgo de discalemia. Las enfermeras de cuidados críticos deben prestar especial atención a los pacientes de alto riesgo de discalemia, y ser proactivas en la identificación de los primeros signos de la misma, con el fin de lograr una evaluación específica del riesgo, mejorar el diagnóstico precoz y la gestión de las condiciones de los pacientes.

Palabras clave:
Discalemia
Factores asociados
Cuidados intensivos

Artículo

Opciones para acceder a los textos completos de la publicación Enfermería Intensiva
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
References
[1]
M. Giordano, T. Ciarambino, P. Castellino, L. Malatino, S. Di Somma, G. Biolo, et al.
Diseases associated with electrolyte imbalance in the ED: age-related differences.
Am J Emerg Med, 34 (2016), pp. 1923-1926
[2]
G. Savarese, H. Xu, M. Trevisan, U. Dahlström, P. Rossignol, B. Pitt, et al.
Incidence, predictors, and outcome associations of dyskalemia in heart failure with preserved, mid range, and reduced ejection fraction.
JACC Heart Fail, 7 (2019), pp. 65-76
[3]
R. Kettritz, J. Loffing.
Potassium homeostasis – physiology and pharmacology in a clinical context.
Pharmacol Ther, 249 (2023),
[4]
K. Sumida, A.A. Dashputre, P.K. Potukuchi, F. Thomas, Y. Obi, M.Z. Molnar, et al.
Laxative use and risk of dyskalemia in patients with advanced CKD transitioning to dialysis.
J Am Soc Nephrol, 32 (2021), pp. 950-959
[5]
B. Brueske, M.S. Sidhu, J. Schulman-Marcus, K.B. Kashani, G.W. Barsness, J.C. Jentzer.
Hyperkalemia is associated with increased mortality among unselected cardiac intensive care unit patients.
J Am Heart Assoc, 8 (2019),
[6]
L. Senninger, L. Abensur Vuillaume, L. Frimat, N. Girerd, Z. Lamiral, P. Rossignol, et al.
Dyskalemia: a management problem for students.
Fundam Clin Pharmacol, 35 (2021), pp. 473-484
[7]
A. Jin, M. Zhao, Y. Sun, X. Feng, R. Zhang, Q. Qiao, et al.
Normal range of serum potassium, prevalence of dyskalaemia and associated factors in Chinese older adults: a cross-sectional study.
[8]
S. Urwin, J. Willows, J.A. Sayer.
The challenges of diagnosis and management of Gitelman syndrome.
Clin Endocrinol, 92 (2020), pp. 3-10
[9]
C. Reddin, J. Ferguson, R. Murphy, A. Clarke, C. Judge, V. Griffith, et al.
Global mean potassium intake: a systematic review and Bayesian meta-analysis.
Eur J Nutr, 62 (2023), pp. 2027-2037
[10]
X. Wan, J. Perry, H. Zhang, F. Jin, K.A. Ryan, C. Van Hout, et al.
Heterozygosity for a pathogenic variant in SLC12A3 that causes autosomal recessive gitelman syndrome is associated with lower serum potassium.
J Am Soc Nephrol, 32 (2021), pp. 756-765
[11]
L. Hessels, M. Hoekstra, L.J. Mijzen, M. Vogelzang, W. Dieperink, A.O. Lansink, et al.
The relationship between serum potassium, potassium variability and in-hospital mortality in critically ill patients and a before–after analysis on the impact of computer-assisted potassium control.
[12]
J. Wang, M. Jin, J. Zheng, Y. Chen, T. Sun, Y. Zheng, et al.
Sociodemographic and clinical factors influencing serum potassium concentration: a retrospective cohort study.
Comput Struct Biotechnol J, 24 (2024), pp. 1-11
[13]
G.M.C. Rosano, J. Tamargo, K.P. Kjeldsen, M. Lainscak, S. Agewall, S.D. Anker, et al.
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin–angiotensin–aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Eur Heart J Cardiovasc Pharmacother, 4 (2018), pp. 180-188
[14]
L. Bouadma, S. Mankikian, M. Darmon, L. Argaud, C. Vinclair, S. Siami, et al.
Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
[15]
K. Tazmini, S.H. Nymo, W.E. Louch, A.H. Ranhoff, E. Øie.
Electrolyte imbalances in an unselected population in an emergency department: a retrospective cohort study.
[16]
C. Fujisawa, H. Umegaki, T. Sugimoto, C.H. Huang, H. Fujisawa, Y. Sugimura, et al.
Older adults with a higher frailty index tend to have electrolyte imbalances.
[17]
L.A. Vuillaume, J.P. Ferreira, N. Asseray, B. Trombert-Paviot, E. Montassier, M. Legrand, et al.
Hypokalemia is frequent and has prognostic implications in stable patients attending the emergency department.
[18]
G. Lindner, E.A. Burdmann, C.M. Clase, B.R. Hemmelgarn, C.A. Herzog, J. Małyszko, et al.
Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.
Eur J Emerg Med, 27 (2020), pp. 329-337
[19]
Rapport de la Sécurité Routière – Bilan de l’année 2022, Agence Nationale de la Sécurité Routière. https://www.narsa.ma/sites/default/files/202310/Rapport%20de%20la%20SR%202022%20V5_231020_140005_compressed.pdf [accessed 10.10.24].
[20]
J. Helms, S. Middeldorp, A.C. Spyropoulos.
Thromboprophylaxis in critical care.
Intensive Care Med, 49 (2023), pp. 75-78
[21]
D.W. Yip, V. Gerriets.
Penicillin.
StatPearls, StatPearls Publishing, (2023),
[22]
WHO EMRO – Journée mondiale de la Santé: ensemble contre le diabète. https://joomla.emro.who.int/fr/mor/morocco-news/journee-mondiale-de-la-sante-ensemble-contre-le-diabete.html [accessed 10.10.24].
[23]
G. Alfano, A. Ferrari, F. Fontana, R. Perrone, G. Mori, E. Ascione, et al.
Hypokalemia in patients with COVID-19.
Clin Exp Nephrol, 25 (2021), pp. 401-409
[24]
J.Y. Seo, E.J. Cho, M.J. Kim, M.S. Kwak, J.I. Yang, S.J. Chung, et al.
The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
J Cach Sarcop Mus, 13 (2022), pp. 2953-2960
[25]
M.A. Flynn, G.B. Nolph, A.S. Baker, W.M. Martin, G. Krause.
Total body potassium in aging humans: a longitudinal study.
Am J Clin Nutr, 50 (1989), pp. 713-717
[26]
N.L. Larivée, J.B. Michaud, K.M. More, J.A. Wilson, K.K. Tennankore.
Hyperkalemia: prevalence, predictors and emerging treatments.
Cardiol Ther, 12 (2023), pp. 35-63
[27]
A. Sarnowski, R.M. Gama, A. Dawson, H. Mason, D. Banerjee.
Hyperkalemia in chronic kidney disease: links, risks and management.
Int J Nephrol Renovasc Dis, 15 (2022), pp. 215-228
[28]
S.L. Seliger.
Hyperkalemia in patients with chronic renal failure.
Nephrol Dial Transplant, 34 (2019), pp. iii12-iii18
[29]
R. Watanabe.
Hyperkalemia in chronic kidney disease.
Rev Assoc Med Bras, 66 (2020), pp. s31-s36
[30]
C.P. Kovesdy, K. Matsushita, Y. Sang, N.J. Brunskill, J.J. Carrero, G. Chodick, et al.
Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
Eur Heart J, 39 (2018), pp. 1535-1542
[31]
N. Navarrete.
Hyperkalemia in electrical burns: a retrospective study in Colombia.
[32]
I. Gutowska, W. Żwierełło, K. Piorun, M. Skórka-Majewicz, D. Maciejewska-Markiewicz, P. Kupnicka, et al.
The extent of burn injury significantly affects serum micro- and macroelement concentrations in patients on the first day of hospitalisation.
Nutrients, 14 (2022), pp. 4248
[33]
A. Kelez Yayik.
Crush syndrome patient care in intensive care unit.
Cerrahpaşa Med J, 47 (2023), pp. 33-37
[34]
J.N. An, J.P. Lee, H.J. Jeon, D.H. Kim, Y.K. Oh, Y.S. Kim, et al.
Severe hyperkalemia requiring hospitalization: predictors of mortality.
Crit Care, 16 (2012), pp. R225
[35]
A. Singh, A.P. Anjankar.
Propofol-related infusion syndrome: a clinical review.
[36]
J. Wolf, L.J. Geneen, A. Meli, C. Doree, R. Cardigan, H.V. New.
Hyperkalaemia following blood transfusion – a systematic review assessing evidence and risks.
Transfus Med Rev, 36 (2022), pp. 133-142
[37]
Z. Nouri, S. Fakhri, K. Nouri, C.E. Wallace, M.H. Farzaei, A. Bishayee.
Targeting multiple signaling pathways in cancer: the rutin therapeutic approach.
[38]
A. Gupta, N. El-Wiher.
Therapeutic challenges in management of severe acidosis and profound hypokalemia in pediatric diabetic ketoacidosis.
Glob Pediatr Health, 6 (2019),
[39]
R.G. Manappallil, J. Nambiar.
Hyperkalemic cardiac arrest in a patient with diabetic ketoacidosis.
Indian J Crit Care Med, 24 (2020), pp. 737-738
[40]
P. Ratanasrimetha, B.T. Workeneh, H. Seethapathy.
Sodium and potassium dysregulation in the patient with cancer.
Adv Chronic Kidney Dis, 29 (2022), pp. 171-179.e1
[41]
I. Verzicco, G. Regolisti, F. Quaini, P. Bocchi, I. Brusasco, M. Ferrari, et al.
Electrolyte disorders induced by antineoplastic drugs.
[42]
J. Kovacs, S. Talib, A. Khashan, B. Garsondiya, M.P. Carson.
A 77-year-old man with heparin-induced aldosterone suppression causing hyperkalemia.
Am J Case Rep, 23 (2022),
[43]
L. Coregliano-Ring, K. Goia-Nishide, É.B. Rangel.
Hypokalemia in diabetes mellitus setting.
asdasdasd
Opciones de artículo
Herramientas